Patents Assigned to Neuron Systems, Inc.
  • PROCESS TO PREPARE 6-CHLORO-3-AMINO-2-(2-HYDROXYPROPYL)-1-AZANAPHTHALENE
    Publication number: 20130190500
    Abstract: This invention relates to a process for the preparation of 6-chloro-3-amino-2-(2-hydroxypropyl)-1-azanapthalene. It comprises treating 6-chloro-3-pyridylium-2-ethoxycarbonyl-1-azanaphthanlene bromide with morpholine at about 80° C., followed by treating the product thereof with methylmagnesium chloride.
    Type: Application
    Filed: December 10, 2012
    Publication date: July 25, 2013
    Applicant: NEURON SYSTEMS, INC.
    Inventor: Neuron Systems, Inc.
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF MACULAR DEGENERATION
    Publication number: 20120302601
    Abstract: The present invention is directed to topical ophthalmic compositions of a lipophilic compound and an oligomeric or polymeric carrier wherein the compositions are useful in the treatment and prevention of macular degeneration. The invention also includes methods of treating macular degeneration by using a topical ophthalmic composition of a lipophilic compound and an oligomeric or polymeric carrier.
    Type: Application
    Filed: December 9, 2010
    Publication date: November 29, 2012
    Applicant: Neuron Systems, Inc.
    Inventors: Thomas A. Jordan, John Clifford Chabala, Gerald D. Cagle
  • Compositions and Methods of Treating Retinal Disease
    Publication number: 20110263645
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed
    Type: Application
    Filed: July 1, 2011
    Publication date: October 27, 2011
    Applicant: Neuron Systems, Inc.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • Compositions and methods of treating retinal disease
    Patent number: 7973025
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Grant
    Filed: May 26, 2006
    Date of Patent: July 5, 2011
    Assignee: Neuron Systems, Inc.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • Compositions and methods of treating retinal disease
    Publication number: 20090182009
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Application
    Filed: May 26, 2006
    Publication date: July 16, 2009
    Applicant: Neuron Systems, Inc.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala